GlaxoSmithKline: all 4,196 studies
Page 21 of 42. Open to participants first (141), then studies with results posted, then the rest; newest registration first within each.
- Safety Study of Pandemic Candidate Influenza Vaccines in the Elderly PopulationCompletedNCT00306995Phase 2Results posted
- VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2CompletedNCT00306293Phase 4Results posted
- Pazopanib In Patients With Relapsed Or Refractory Soft Tissue SarcomaCompletedNCT00297258Phase 2Results posted
- Study In Patients With Depression Not Responding to Selective Serotonin Re-uptake InhibitorsCompletedNCT00296517Phase 3Results posted
- A Study To Assess GW433908 (Fosamprenavir) Containing Regimens In HIV-1 Infected SubjectsCompletedNCT00296504Phase 3Results posted
- Study Of Allergic Rhinitis In Patients Who Also Have AsthmaCompletedNCT00296491Phase 4Results posted
- Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and OlderCompletedNCT00294047Phase 3Results posted
- Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine Injected According to a 0, 12-month ScheduleCompletedNCT00291876Phase 4Results posted
- Immune Response & Safety of GSK Biologicals' Mencevax™ ACWY in Subjects Primed in the DTPW-HBV=HIB-MENAC-TT-011 StudyCompletedNCT00291343Phase 3Results posted
- Study to Test the Efficacy of the Vaccine GSK 249553 in Treating Non-small-cell Lung Cancer After Tumour Removal by SurgeryCompletedNCT00290355Phase 2Results posted
- Evaluation of the Immunogenicity, Safety and Reactogenicity of the Combined DTPa-IPV Vaccine in Healthy InfantsCompletedNCT00290342Phase 3Results posted
- Safety of Purified Meningococcal Vaccine With Serogroups ACWY, in 3,000 Filipino Subjects Aged > 2 YearsCompletedNCT00290329Phase 4Results posted
- Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate VaccineCompletedNCT00289783Phase 3Results posted
- Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy AdultsCompletedNCT00289770Phase 3Results posted
- Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine, Injected According to 0, 6-month ScheduleCompletedNCT00289757Phase 4Results posted
- Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month ScheduleCompletedNCT00289744Phase 3Results posted
- Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B VaccCompletedNCT00289731Phase 4Results posted
- Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month ScheduleCompletedNCT00289718Phase 3Results posted
- Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)CompletedNCT00289198Phase 3Results posted
- Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian InfantsCompletedNCT00289185Phase 2Results posted
- US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal DiseaseCompletedNCT00282295Phase 4Results posted
- SB-705498 Dental Pain Study After Tooth ExtractionCompletedNCT00281684Phase 2Results posted
- A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian CancerCompletedNCT00281632Phase 2Results posted
- COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With HypertensionCompletedNCT00273052Phase 3Results posted
- GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema)CompletedNCT00269087Phase 3Results posted
- Integrated Biomarker And Imaging Study - 2CompletedNCT00268996Phase 2Results posted
- Comparison Of Rituximab Versus Tositumomab and Iodine I 131 Tositumomab (BEXXAR® Therapeutic Regimen) For Patients With Relapsed Follicular Non-Hodgkins LymphomaCompletedNCT00268983Phase 3Results posted
- Expanded Access Study Of BEXXAR® For Low Grade And Transformed Low-Grade Non-Hodgkin's LymphomaCompletedNCT00268203Phase 2Results posted
- Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial CancerCompletedNCT00267488Phase 2Results posted
- Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's DiseaseCompletedNCT00265148Phase 2Results posted
- A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South AfricaCompletedNCT00263666Phase 2Results posted
- A Study In Patients With Type 2 Diabetes MellitusCompletedNCT00256867Phase 3Results posted
- Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome)CompletedNCT00256854Phase 3Results posted
- Evaluation of the Immune Responses of GSK Biologicals' HPV Vaccine Following Manufacturing Process Adaptation.CompletedNCT00250276Phase 3Results posted
- GW786034 In Subjects With Locally Recurrent Or Metastatic Clear Cell Renal Cell CarcinomaCompletedNCT00244764Phase 2Results posted
- Antifibrotic Activity Of GI262570 In Chronic Hepatitis C SubjectsCompletedNCT00244751Phase 2Results posted
- Odiparcil For The Prevention Of Venous ThromboembolismCompletedNCT00244725Phase 2Results posted
- Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIVCompletedNCT00244712Phase 4Results posted
- Vaccine Efficacy Against Rotavirus Diarrhea; Vaccine Given With Routine Childhood Vaccinations in Healthy African InfantsCompletedNCT00241644Phase 3Results posted
- Long Term Follow-Up Study 16-20 Years After Hepatitis B Vaccination in Newborns of Mothers Who Were Seropositive for Hepatitis B Envelope Antigen (HBeAg) & Hepatitis B Surface Antigen (HBsAg)CompletedNCT00240539Phase 4Results posted
- LT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ MothersCompletedNCT00240526Phase 4Results posted
- Follow-up Study 16-20 Years After Primary Vaccination Against Hepatitis B of Newborns From HBeAg+ & HBsAg+ MothersCompletedNCT00240500Phase 4Results posted
- A Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US AdultsCompletedNCT00239577Phase 2Results posted
- Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in EpilepsyCompletedNCT00235755Phase 3Results posted
- Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in EpilepsyCompletedNCT00232596Phase 3Results posted
- Human Papilloma Virus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Bio's Novel HPV Vaccine.CompletedNCT00231413Phase 2Results posted
- Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in ChildrenCompletedNCT00228917Phase 3Results posted
- Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and ChickenpoxCompletedNCT00226499Phase 3Results posted
- Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years OldCompletedNCT00224484Phase 3Results posted
- Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 MonthsCompletedNCT00197236Phase 3Results posted
- Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were ComparedCompletedNCT00197184Phase 3Results posted
- Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected SubjectsTerminatedNCT00197145Phase 3Results posted
- Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 YearsCompletedNCT00197119Phase 3Results posted
- Treatment Of Symptomatic Asthma In ChildrenCompletedNCT00197106Phase 4Results posted
- Examine Safety and Immune Responses of GSK 257049 Vaccine When Administered to Infants Living in a Malaria-endemic RegionCompletedNCT00197028Phase 2Results posted
- Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in ChildrenCompletedNCT00197015Phase 3Results posted
- Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of AgeCompletedNCT00197002Phase 3Results posted
- Safety & Immunogenicity of 1 Dose of GSK134612 in Children 12-14 Months and 3-5 Years OldCompletedNCT00196976Phase 2Results posted
- Human Papilloma Virus (HPV) Vaccine Immunogenicity and Safety Trial in Young and Adult Women With GSK Biologicals' HPV-16/18CompletedNCT00196937Phase 3Results posted
- Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in InfantsCompletedNCT00169442Phase 3Results posted
- A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies.CompletedNCT00158860Phase 4Results posted
- Immune Response Post Pry Vaccination of 2 Formulations of DTPw-HBV Vaccine Given With Rotavirus Vaccine to InfantsCompletedNCT00158756Phase 3Results posted
- Immune Response and Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV VaccinesCompletedNCT00148941Phase 3Results posted
- Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30mCompletedNCT00136604Phase 3Results posted
- Study Of 323U66 SR In Major Depressive DisorderCompletedNCT00135512Phase 2Results posted
- Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate VaccinesCompletedNCT00134719Phase 2Results posted
- Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal VaccineCompletedNCT00129129Phase 2Results posted
- 3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of AgeCompletedNCT00129116Phase 2Results posted
- Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy ParticipantsCompletedNCT00128661Phase 3Results posted
- Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) VaccineCompletedNCT00127855Phase 2Results posted
- Detection and Characterisation of Varicella Zoster Virus From Dermal Lesions of Chickenpox-infected PatientsCompletedNCT00127608Phase 3Results posted
- Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18CompletedNCT00122681Phase 3Results posted
- A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or ExerciseCompletedNCT00118716Phase 4Results posted
- Once-Daily Investigational Nasal Spray In Adults And Adolescents With Vasomotor RhinitisCompletedNCT00118703Phase 3Results posted
- Study Of Adults And Adolescents With Vasomotor RhinitisCompletedNCT00117325Phase 3Results posted
- VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.CompletedNCT00116844Phase 4Results posted
- Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 DiabetesCompletedNCT00116831Phase 3Results posted
- A New Oral Treatment For Type II Diabetes MellitusCompletedNCT00111800Phase 2Results posted
- The CLEVER Study - Coreg And Left Ventricular Mass RegressionCompletedNCT00108082Phase 3Results posted
- Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) SeizuresCompletedNCT00104416Phase 3Results posted
- Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced NonCCR5-Tropic HIV-1 Infected SubjectsCompletedNCT00098748Phase 2/3Results posted
- Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected SubjectsCompletedNCT00098722Phase 2/3Results posted
- Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected SubjectsCompletedNCT00098306Phase 2/3Results posted
- Trial of Maraviroc (UK-427,857) in Combination With Zidovudine/Lamivudine Versus Efavirenz in Combination With Zidovudine/LamivudineCompletedNCT00098293Phase 3Results posted
- Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic SyndromeTerminatedNCT00097370Phase 3Results posted
- Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination TreatmentCompletedNCT00090103Phase 3Results posted
- Lapatinib In Chemotherapy-Naive Or Metastatic Breast CancerCompletedNCT00089999Phase 2Results posted
- GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In AdultsCompletedNCT00089986Phase 2Results posted
- Study Of Ispinesib In Subjects With Breast CancerCompletedNCT00089973Phase 2Results posted
- 48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV InfectionCompletedNCT00089583Phase 2Results posted
- Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast CancerCompletedNCT00075270Phase 3Results posted
- A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung CancerTerminatedNCT00073008Phase 2Results posted
- A Safety and Efficacy Study of LymphoStat-B™ (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthritis (RA)CompletedNCT00071812Phase 2Results posted
- Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric SubjectsCompletedNCT00071760Phase 2Results posted
- Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE)CompletedNCT00071487Phase 2Results posted
- Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung CancerCompletedNCT00065182Phase 2Results posted
- HerpeVac Trial for Young WomenCompletedNCT00057330Phase 3Results posted
- "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased RiskCompletedNCT00056407Phase 3Results posted
- A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 YearsCompletedNCT00040664Phase 2Results posted
- A Comparative Study to Investigate the Difference in Blood Levels of Two Different Formulations of GSK5784283Active, not recruitingNCT07712393Phase 1